Levocetirizine + Ambroxol HydrochlorideThird Party Manufacturing in India

Levocetirizine + Ambroxol Hydrochloride works by combining competitive peripheral H1 receptor blockade with active secretolytic action. It inhibits allergic histamine symptoms and thins thick bronchial mucus to help the body clear respiratory tract secretions comfortably. Unlike dry-cough alternative classes, it addresses productive cough complicated by allergic bronchospasm. It is highly effective and well-tolerated across allergy seasons. The manufacturing process coordinates the blending of active agents linked to CAS 130018-87-0 and mucolytic substrates to ensure uniform dose distribution.

Companies searching for Levocetirizine + Ambroxol Hydrochloride third party manufacturing in India can tap into Celesta Healthcare's broad operational capabilities to secure high-demand respiratory combinations.

Therapeutic Uses

• Productive Cough with Allergy: Clears viscous mucus while relieving associated allergic upper respiratory symptoms.
• Chronic Obstructive Bronchitis: Enhances expectoration and reduces asthmatic cough frequency.

Why Manufacturers Choose Levocetirizine + Ambroxol Hydrochloride

This combo is a top-selling respiratory prescription during seasonal shifts. Our partner facilities are WHO-GMP certified, which ensures rigorous moisture controls during manufacturing to prevent the decomposition of sensitive active salts and maintain premium dissolution rates.